Prudent use of antibiotics: are our expectations justified?

Prudent use of antibiotics has 3 components, rational use, adherence to local guidelines and policies, and avoidance or reversal of upward demographic trends in antibiotic resistance. Although rational use is mandatory, it must be recognized that adherence to policies will reduce clinical freedom, for good or ill. Expectations that prudent use will deliver reversals in resistance trends should be accepted with caution. Sound, pertinent data are lacking, and our ability to detect change, if it does occur, and to attribute its cause correctly, is questionable.

[1]  I. Phillips,et al.  Antibiotic clinical trials—the Witley Park Symposium , 1999 .

[2]  I. Phillips The use of bacitracin as a growth promoter in animals produces no risk to human health. , 1999, The Journal of antimicrobial chemotherapy.

[3]  F. Dunstan,et al.  Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8 , 1999, BMJ.

[4]  I. Phillips Assessing the evidence that antibiotic growth promoters influence human infections. , 1999, The Journal of hospital infection.

[5]  I. Phillips Lessons from the past: a personal view. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. E. Jensen,et al.  Resistance to antimicrobial agents used for animal therapy in pathogenic‐, zoonotic‐ and indicator bacteria isolated from different food animals in Denmark: a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP) , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[7]  I. Phillips The 1997 Garrod Lecture. The subtleties of antibiotic resistance. , 1998, The Journal of antimicrobial chemotherapy.

[8]  D. Livermore,et al.  Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. , 1998, The Journal of antimicrobial chemotherapy.

[9]  V. Morell Antibiotic Resistance: Road of No Return , 1997, Science.

[10]  P Huovinen,et al.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.

[11]  S. Schrag,et al.  Reducing antibiotic resistance , 1996, Nature.

[12]  I. Phillips,et al.  Occurrence of FIme plasmids in multiply antimicrobial-resistant Escherichia coli isolated from urinary tract infection , 1993, Epidemiology and Infection.

[13]  M. Ridley,et al.  Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies. , 1970, Lancet.

[14]  A. Fleming Penicillin: Its Practical Application , 1947 .